Benefits of PETN on endothelial function and oxidative stress in diabetes;Endothelfunktion und oxidativer stress bei diabetes - Nutzen eines langzeitnitrats

Diabetes, Stoffwechsel und Herz

Volumn 18, Issue 1, 2009, Pages 21-27

  Schnell, Oliver ^a,d   Stalleicken, D ^b   Marx, N ^c  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^b Actavis Deutschland   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Diabetes; Endothel; Myocardial infarction; Pantaerythritol tetranitrate; PETN

Indexed keywords

CALCIUM; ENDOTHELIUM DERIVED RELAXING FACTOR; GLYCERYL TRINITRATE; NITRIC OXIDE; PENTAERYTHRITYL TETRANITRATE; PROSTACYCLIN;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOAVAILABILITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL PROTECTION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DRUG ACTIVITY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; HUMAN; INSULIN RESISTANCE; OXIDATIVE STRESS; REVIEW; VASODILATATION;

EID: 59349115036     PISSN: 18617603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Standl E, Schnell O: A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia 2000; 43: 1455-1469
2. Schnell O, Standi E: Impaired glucose tolerance, diabetes, and cardiovascular disease. Endocr Pract 2006; 12 (Suppl 1): 16-19
3. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, Kereiakes DJ, Topol EJ: Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 1993; 21: 920-925
4. Lowel H, Koenig W, Engel S, Hormann A, Keil U: The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 2000; 43: 218-226
5. Otter W, Kleybrink S, Doering W, Standl E, Schnell O: Hospital outcome of acute myocardial infarction in patients with and without diabetes mellitus. Diabet Med 2004; 21: 183-187
6. Williams B, Gallacher B, Patel H, Orme C: Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 1997; 46: 1497-1503
7. Hattori N, Schnell O, Bengel FM, Rihl J, Nekolla SG, Drzezga AE, Standl E, Schwaiger M: Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus. Eur J Nucl Med Mol Imaging 2002; 29: 891-898
8. Chan NN, Vallance P, Colhoun HM: Nitric oxide and vascular responses in Type I diabetes. Diabetologia 2000; 43: 137-147
9. Palmer RM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327(6122): 524-526
10. Sartori C, Scherrer U: Insulin, nitric oxide and the sympathetic nervous system: at the crossroads of metabolic and cardiovascular regulation. J Hypertens 1999; 17: 1517-1525
11. Wilson SH, Celermajer DS, Nakagomi A, Wyndham RN, Janu MR, Ben Freedman S: Vascular risk factors correlate to the extent as well as the severity of coronary atherosclerosis. Coron Artery Dis 1999; 10: 449-453
12. Celermajer DS: Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol 1997; 30: 325-333
13. Pieper GM, Gross GJ: Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 1988; 255(4 Pt 2): H825-H833
14. Rosen P, Ballhausen T, Stockklauser K: Impairment of endothelium dependent relaxation in the diabetic rat heart: mechanisms and implications. Diabetes Res Clin Pract 1996; 31 (Suppl): 143-155
15. Weisbrod RM, Brown ML, Cohen RA: Effect of elevated glucose on cyclic GMP and eicosanoids produced by porcine aortic endothelium. Arterioscler Thromb 1993; 13: 915-923
16. Di Carli MF, Tobes MC, Mangner T, Levine AB, Muzik O, Chakroborty P, Levine TB: Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med 1997; 336: 1208-1215
17. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS: Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998; 280: 913-920
18. Schwaiger M, Melin J: Cardiological applications of nuclear medicine. Lancet 1999; 354(9179): 661-666
19. Di Carli MF, Bianco-Batlles D, Landa ME, Kazmers A, Groehn H, Muzik O, Grunberger G: Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus. Circulation 1999; 100: 813-819
20. Pitkanen OP, Nuutila P, Raitakari OT, Ronnemaa T, Koskinen PJ, Iida H, Lehtimaki TJ, Laine HK, Takala T, Viikari JS, Knuuti J: Coronary flow reserve is reduced in young men with IDDM. Diabetes 1998; 47: 248-254
21. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, Omata M: Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997; 30: 1472-1477
22. Hattori N, Rihl J, Bengel FM, et al. (2003) Cardiac autonomic dysinnervation and myocardial blood flow in long-term Type 1 diabetic patients. Diabet Med 20: 375-381
23. Momose M, Abletshauser C, Neverve J, et al. (2002) Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus. Eur J Nucl Med Mol Imaging 29: 1675-1679
24. Kichuk MR, Seyedi N, Zhang X, Marboe CC, Michler RE, Addonizio LJ, Kaley G, Nasjletti A, Hintze TH: Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 1996; 94: 44-51
25. Baumgartner-Parzer SM, Wagner L, Pettermann M, Gessl A, Waldhausl W: Modulation by high glucose of adhesion molecule expression in cultured endothelial cells. Diabetologia 1995; 38: 1367-1370
26. Fasching P, Veitl M, Rohac M, Streli C, Schneider B, Waldhausl W, Wagner OF: Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4313-4317
27. Lorenzi M, Cagliero E: Pathobiology of endothelial and other vascular cells in diabetes mellitus. Call for data. Diabetes 1991; 40: 653-659
28. Knight JA: Free radicals: their history and current status in aging and disease. Ann Clin Lab Sci 1998; 28: 331-346
29. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414(6865): 813-820
30. Ceriello A: Oxidative stress and diabetes-associated complications. Endocr Pract 2006; 12 (Suppl 1): 60-62
31. Ceriello A: Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care 2008; 31 (Suppl 2): S181-S184
32. Kruger AL, Peterson SJ, Schwartzman ML, Fusco H, McClung JA, Weiss M, Shenouda S, Goodman AI, Goligorsky MS, Kappas A, Abraham NG: Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects. J Pharmacol Exp Ther 2006; 319: 1144-1152
33. Immenschuh S, Ramadori G: Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 2000; 60: 1121-1128
34. Otterbein LE, Choi AM: Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000; 279: 1029-1037
35. Polte T, Abate A, Dennery PA, Schroder H: Heme oxygenase-1 is a cGMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler Thromb Vasc Biol 2000; 20: 1209-1215
36. Perrella MA, Yet S-F (2003) Role of heme oxygenase-1 in cardiovascular function. Curr Pharm Des 9: 2479-2487
37. Chen YH, Yet SF, Perrella MA (2003) Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Exp Biol Med (Maywood) 228: 447-453
38. Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, Balla G: Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant 2003; 18 (Suppl 5): v8-v12
39. Perrella MA, Yet SF: Role of heme oxygenase-1 in cardiovascular function. Curr Pharm Des 2003; 9: 2479-2487
40. Takahashi T, Shimizu H, Morimatsu H, Inoue K, Akagi R, Morita K, Sassa S: Heme oxygenase-1: a fundamental guardian against oxidative tissue injuries in acute inflammation. Mini Rev Med Chem 2007; 7: 745-753
41. Vitek L, Schwertner HA: The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007; 43: 1-57
42. Hopkins PN, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR: Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1996; 16: 250-255
43. Mayer M: Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000; 46: 1723-1727
44. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW, Vercellotti GM: Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem 1992; 267: 18148-18153
45. Munzel T, Sayegh H, Freeman BA, Tarpey MM, Harrison DG: Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J Clin Invest 1995; 95: 187-194
46. Schulz E, Tsilimingas N, Rinze R, Reiter B, Wendt M, Oelze M, Woelken-Weckmuller S, Walter U, Reichenspurner H, Meinertz T, Munzel T: Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation 2002; 105: 1170-1175
47. Munzel T, Daiber A, Mulsch A: Explaining the phenomenon of nitrate tolerance. Circ Res 2005; 97: 618-628
48. Thomas GR, Di Fabio JM, Gori T, Parker JD: Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J Am Coll Cardiol 2007; 49: 1289-1295
49. Sekiya M, Sato M, Funada J, Ohtani T, Akutsu H, Watanabe K: Effects of the long-term administration of nicorandil on vascular endothelial function and the progression of arteriosclerosis. J Cardiovasc Pharmacol 2005; 46: 63-67
50. Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD: Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol 2001; 38: 854-859
51. Gori T, Al-Hesayen A, Jolliffe C, Parker JD: Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers. Am J Cardiol 2003; 91: 1392-1394
52. Wenzel P, Oelze M, Coldewey M, Hortmann M, Seeling A, Hink U, Mollnau H, Stalleicken D, Weiner H, Lehmann J, Li H, Forstermann U, Munzel T, Daiber A: Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler Thromb Vasc Biol 2007; 27: 1729-1735
53. Dikalov S, Fink B, Skatchkov M, Stalleicken D, Bassenge E: Formation of reactive oxygen species by pentaerithrityltetranitrare and glyceryl trinitrate in vitro and development of nitrate tolerance. J Pharmacol Exp Ther 1998; 286: 938-944
54. Kojda G, Hacker A, Noack E: Effects of non-intermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production. Eur J Pharmacol 1998; 355: 23-31
55. Kojda G, Stein D, Kottenberg E, Schnaith EM, Noack E: In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits. J Cardiovasc Pharmacol 1995; 25: 763-773
56. Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN: Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci U S A 1991; 88: 688-692
57. Harrison PM, Arosio P: The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996; 1275: 161-203
58. Kim YM, Bergonia H, Lancaster JR: Nitrogen oxide-induced autoprotection in isolated rat hepatocytes. FEBS Lett 1995; 374: 228-232
59. Oberle S, Schroder H: Ferritin may mediate SIN-1-induced protection against oxidative stress. Nitric Oxide 1997; 1: 308-314
60. Yee EL, Pitt BR, Billiar TR, Kim YM: Effect of nitric oxide on heme metabolism in pulmonary artery endothelial cells. Am J Physiol 1996; 271(4 Pt 1): 512-518
61. Oberle S, Abate A, Grosser N, Vreman HJ, Dennery PA, Schneider HT, Stalleicken D, Schroder H: Heme oxygenase-1 induction may explain the antioxidant profile of pentaerythrityl trinitrate. Biochem Biophys Res Commun 2002; 290: 1539-1544
62. Oberle S, Schwartz P, Abate A, Schroder H: The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells. Biochem Biophys Res Commun 1999; 261: 28-34
63. Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mulsch A, Munzel T: Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol 2004; 66: 1372-1382
64. Daiber A, Oelze M, Sulyok S, Coldewey M, Schulz E, Treiber N, Hink U, Mulsch A, Scharffetter-Kochanek K, Munzel T: Heterozygous deficiency of manganese superoxide dismutase in mice (Mn-SOD+/-): a novel approach to assess the role of oxidative stress for the development of nitrate tolerance. Mol Pharmacol 2005; 68: 579-588
65. Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, Ullrich V, Mulsch A, Schulz E, Keaney JF, Stamler JS, Munzel T: Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest 2004; 113: 482-489
66. Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, Kitagawa K, Nakayama KI, Hess DT, Stamler JS: An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A 2005; 102: 12159-12164
67. Chen Z, Zhang J, Stamler JS: Identification of the enzymatic mechanism of nitroglycerin bioactivation. Proc Natl Acad Sci U S A 2002; 99: 8306-8311
68. Wenzel P, Hink U, Oelze M, Seeling A, Isse T, Bruns K, Steinhoff L, Brandt M, Kleschyov AL, Schulz E, Lange K, Weiner H, Lehmann J, Lackner KJ, Kawamoto T, Munzel T, Daiber A: Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice. Br J Pharmacol 2007; 150: 526-533
69. Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, Ho KK, Weiner H, Bachschmid M, Munzel T, Daiber A: Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem 2007; 282: 792-799
70. Mollnau H, Wenzel P, Oelze M, Treiber N, Pautz A, Schulz E, Schuhmacher S, Reifenberg K, Stalleicken D, Scharffetter-Kochanek K, Kleinert H, Munzel T, Daiber A: Mitochondrial oxidative stress and nitrate tolerance - comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice. BMC Cardiovasc Disord 2006; 6: 44
71. Converso DP, Taille C, Carreras MC, Jaitovich A, Poderoso JJ, Boczkowski J: HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J 2006; 20: 1236-1238
72. Dikalov S, Fink B, Skatchkov M, Bassenge E: Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: effect of vitamin C. Free Radic Biol Med 1999; 27: 170-176
73. Schulz S, Oberle-Plümpe S, Grosser N, Abate A, Vreman HJ, Dennery PA, Stevenson DK, Schröder H: Pentaerythritol tetranitrate reduces free radical formation in endothelial cells and macrophages - involvement of heme oxygenase-1. NaunynSchmiedberg's Arch Pharmacol 2005; 371 (Suppl 1): R40; Frühjahrstagung der DGPT 2005
74. Gueler F, Park JK, Rong S, Kirsch T, Lindschau C, Zheng W, Elger M, Fiebeler A, Fliser D, Luft FC, Haller H: Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages. Am J Pathol 2007; 170: 1192-1199
75. McDonagh AF: Is bilirubin good for you? Clin Perinatol 1990; 17: 359-369
76. Dragoni S, Gori T, Lisi M, Di Stolfo G, Pautz A, Kleinert H, Parker JD: Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion. Arterioscler Thromb Vasc Biol 2007; 27: 1955-1959
77. Koenig A, Lange K, Konter J, Daiber A, Stalleicken D, Glusa E, Lehmann J: Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate. J Cardiovasc Pharmacol 2007; 50: 68-74
78. Daiber A, Wenzel P, Oelze M, Munzel T: New insights into bioactivation of organic nitrates, nitrate tolerance and cross-tolerance. Clin Res Cardiol 2008; 97: 12-20
79. Coceani F: Carbon monoxide in vasoregulation: the promise and the challenge. Circ Res 2000; 86: 1184-1186
80. Abraham NG, Asija A, Drummond G, Peterson S: Heme oxygenase-1 gene therapy: recent advances and therapeutic applications. Curr Gene Ther 2007; 7(2): 89-108
81. Koizumi S: Human heme oxygenase-1 deficiency: a lesson on serendipity in the discovery of the novel disease. Pediatr Int 2007; 49: 125-132
82. Ryter SW, Alam J, Choi AMK: Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 2006; 86: 583-650
83. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S: Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103: 129-135